TNF Regulates the In Vivo Occupancy of Both Distal and Proximal Regulatory Regions of the MCP-1/JE Gene

AbstractIn vivo genomic footprinting (IVGF) was used to examine regulatory site occupancy during the activation of the murine inflammatory response gene MCP-1/JE by TNF. In response to TNF, both promoter distal and proximal regulatory regions became occupied in vivo. EMSA analysis showed that while some of the factors involved in expression, including NF-κB, were translocated to the nucleus following TNF treatment, others were already present and able to bind DNA in vitro. Protein kinase inhibitor studies showed that protein phosphorylation was required for TNF activation but not factor assembly. These studies provide evidence for a multistep model of TNF-mediated gene regulation involving chromatin accessibility, transcription factor complex assembly, and protein phosphorylation

Meson PVV Interactions are determined by Quark Loops

We show that all abnormal parity three-body meson interactions can be adequately described by quark loops, evaluated at zero external momentum, with couplings determined by $U(N_f)$ symmetry. We focus primarily on radiative meson decays which involve one pseudoscalar. The agreement with experiment for non-rare decays is surprisingly good and requires very few parameters, namely the coupling constants $g_{\pi qq}$ and $g_{\rho qq}$ and some mixing angles. This agreement extends to some three-body decays that are dominated by pion pairs in a P-wave state.Comment: 21 pages, Revtex, one figur

Quantum interference in a four-level system of a 87Rb^{87}\mathrm{Rb} atom: Effects of spontaneously generated coherence

In this work, the effects of quantum interference and spontaneously generated coherence (SGC) are theoretically analyzed in a four level system of a $^{87}\mathrm{Rb}$ atom. For the effects of SGC, we find that a new kind of EIT channel can be induced due to destructive interference, and the nonlinear Kerr absorption can be coherently narrowed or eliminated under different strengths of the coupling and switching fields.Comment: 9 pages, 5 figure

Absence of antiretroviral therapy and other risk factors for morbidity and mortality in Malaysian compulsory drug detention and rehabilitation centers

Background: Throughout Asia, people who use drugs are confined in facilities referred to as compulsory drug detention and rehabilitation centers. The limited transparency and accessibility of these centers has posed a significant challenge to evaluating detainees and detention conditions directly.Despite HIV being highly prevalent in this type of confined setting, direct evaluation of detainees with HIV and their access to medical care has yet to be reported in the literature. Methods: We evaluated the health status of 100 adult male detainees with HIV and their access to medical care in the two largest Malaysian compulsory drug detention and rehabilitation centers holding HIV-infected individuals.Results: Approximately 80% of all detainees with HIV were surveyed in each detention center. Most participants reported multiple untreated medical conditions. None reported being able to access antiretroviral therapy during detention and only 9% reported receiving any HIV-related clinical assessment or care. Nearly a quarter screened positive for symptoms indicative of active tuberculosis, yet none reported having been evaluated for tuberculosis.Although 95% of participants met criteria for opioid dependence prior to detention, none reported being able to access opioid substitution therapy during detention, with 86% reporting current cravings for opioids and 87% anticipating relapsing to drug use after release.Fourteen percent of participants reported suicidal ideation over the previous two weeks.Conclusion: We identified a lack of access to antiretroviral therapy in two of the six compulsory drug detention and rehabilitation centers in Malaysia designated to hold HIV-infected individuals and found significant, unmet health needs among detainees with HIV. Individuals confined under such conditions are placed at considerably high risk for morbidity and mortality.Our findings underscore the urgent need for evidence-based drug policies that respect the rights of people who use drugs and seek to improve, rather than undermine, their health

Non-Universal Correction To Z→bbˉZ \to b {\bar{b}} And Flavor Changing Neutral Current Couplings

A non-universal interaction associated with top quark induces flavor changing neutral currents (FCNC) among light fermions. The size of the FCNC effect depends crucially on the dynamics of the fermion mass generation. In this paper, we study the effect of a non-universal interaction on $Z b b$, $Z b s$ {\it etc}, by using an effective lagrangian technique and assuming the quark mass matrices in the form of a generalized Fritzsch ansatz. We point out that if fitting $R_b$ to the LEP data within $1 \sigma$, the induced FCNC couplings are very close to the experimental limits.Comment: 9 pages, Te

Analysis of Charge Asymmetry in Rare Dilepton BB Decays

We analyze forward-backward charge asymmetry of the lepton production in rare decays $B\rightarrow X_s l^+l^-$ and $B\rightarrow K^* l^+l^-$, including vector-resonance effects. Certain regions of phase space, in which the asymmetry is sensitive to individual short-distance coefficients, are pointed out. In particular, we suggest a method to test the coupling of the leptonic axial vector current to the left-handed quark current experimentally.Comment: 27 pages, 4 figures available up to requiremen

Radiative decays of heavy and light mesons in a quark triangle approach

The radiative meson decays $V\to P\gamma$ and $P\to \gamma\gamma$ are analyzed using the quark triangle diagram. Experimental data yield well determined estimates of the universal quark-antiquark-meson couplings $g_{Vq\bar{q}'}$ and $g_{Pq\bar{q}'}$ for the light meson sector. Also predictions for the ratios of neutral to charged heavy meson decay coupling constants are given and await experimental confirmation.Comment: 31 pages of RevTex, 5 figures, Postscript version available at http://info.utas.edu.au/docs/physics/theory/Publications/9548.html, scheduled to appear in Phys. Rev. D, vol 53, issue 11, 199

Longitudinal Bioluminescence Imaging of Primary Versus Abdominal Metastatic Tumor Growth in Orthotopic Pancreatic Tumor Models in NSG Mice

Objectives: The purpose of the present study was to develop and validate noninvasive bioluminescence imaging methods for differentially monitoring primary and abdominal metastatic tumor growth in mouse orthotopic models of pancreatic cancer. Methods: A semiautomated maximum entropy segmentation method was implemented for the primary tumor region of interest, and a rule-based method for manually drawing a region of interest for the abdominal metastatic region was developed for monitoring tumor growth in orthotopic models of pancreatic cancer. The 2 region-of-interest methods were validated by having 2 observers independently segment Panc-1 tumors, and the results were compared with the number of mesenteric lymph node nodules and histopathologic assessment of liver metastases. The findings were extended to orthotopic tumors of the more metastatic MIA PaCa-2 and AsPC-1 cells where separate groups of animals were implanted with different numbers of cells. Results: The results demonstrated that the segmentation methods were highly reliable, reproducible, and robust and allowed statistically significant discrimination in the growth rates of primary and abdominal metastatic tumors of different cell lines implanted with different numbers of cells. Conclusions: The present results demonstrate that primary tumors and abdominal metastatic foci in orthotopic pancreatic cancer models can be reliably quantified separately and noninvasively over time with bioluminescence imaging

Heavy quark supermultiplet excitations

Lorentz covariant wave functions for meson and baryon supermultiplets are simply derived by boosting $SU(2)_J$ representations corresponding to multiquark systems at rest.Comment: 12 pages (Revtex), UTAS-PHYS-93-4

A One Health overview, facilitating advances in comparative medicine and translational research.

Table of contentsA1 One health advances and successes in comparative medicine and translational researchCheryl StroudA2 Dendritic cell-targeted gorilla adenoviral vector for cancer vaccination for canine melanomaIgor Dmitriev, Elena Kashentseva, Jeffrey N. Bryan, David T. CurielA3 Viroimmunotherapy for malignant melanoma in the companion dog modelJeffrey N. Bryan, David Curiel, Igor Dmitriev, Elena Kashentseva, Hans Rindt, Carol Reinero, Carolyn J. HenryA4 Of mice and men (and dogs!): development of a commercially licensed xenogeneic DNA vaccine for companion animals with malignant melanomaPhilip J. BergmanA5 Successful immunotherapy with a recombinant HER2-expressing Listeria monocytogenes in dogs with spontaneous osteosarcoma paves the way for advances in pediatric osteosarcomaNicola J. Mason, Josephine S. Gnanandarajah, Julie B. Engiles, Falon Gray, Danielle Laughlin, Anita Gaurnier-Hausser, Anu Wallecha, Margie Huebner, Yvonne PatersonA6 Human clinical development of ADXS-HER2Daniel O'ConnorA7 Leveraging use of data for both human and veterinary benefitLaura S. TremlA8 Biologic replacement of the knee: innovations and early clinical resultsJames P. StannardA9 Mizzou BioJoint Center: a translational success storyJames L. CookA10 University and industry translational partnership: from the lab to commercializationMarc JacobsA11 Beyond docking: an evolutionarily guided OneHealth approach to drug discoveryGerald J. Wyckoff, Lee Likins, Ubadah Sabbagh, Andrew SkaffA12 Challenges and opportunities for data applications in animal health: from precision medicine to precision husbandryAmado S. GuloyA13 A cloud-based programmable platform for healthHarlen D. HaysA14 Comparative oncology: One Health in actionAmy K. LeBlancA15 Companion animal diseases bridge the translational gap for human neurodegenerative diseaseJoan R. Coates, Martin L. Katz, Leslie A. Lyons, Gayle C. Johnson, Gary S. Johnson, Dennis P. O'BrienA16 Duchenne muscular dystrophy gene therapyDongsheng DuanA17 Polycystic kidney disease: cellular mechanisms to emerging therapiesJames P. CalvetA18 The domestic cat as a large animal model for polycystic kidney diseaseLeslie A. Lyons, Barbara GandolfiA19 The support of basic and clinical research by the Polycystic Kidney Disease FoundationDavid A. BaronA20 Using naturally occurring large animal models of human disease to enable clinical translation: treatment of arthritis using autologous stromal vascular fraction in dogsMark L. WeissA21 Regulatory requirements regarding clinical use of human cells, tissues, and tissue-based productsDebra A. WebsterA22 Regenerative medicine approaches to Type 1 diabetes treatmentFrancis N. KaranuA23 The zoobiquity of canine diabetes mellitus, man's best friend is a friend indeed-islet transplantationEdward J. RobbA24 One Medicine: a development model for cellular therapy of diabetesRobert J. Harman